EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts

Rahaf Mahmoud Altahan iD, Natalie Mathews iD, Alex Bourguignon iD, Subia Tasneem iD, Donald M Arnold iD, Wendy Lim iD, Catherine P M Hayward iD

International Journal of Laboratory Hematology · 2024

DOI: 10.1111/ijlh.14216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2024. Verfasst von Rahaf Mahmoud Altahan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: von Willebrand Diseases, Thrombocytopenia, Blood Platelet Disorders, Platelet-Rich Plasma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: McMaster University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Light transmission aggregometry (LTA) is important for diagnosing platelet function disorders (PFD) and von Willebrand disease (VWD) affecting ristocetin‐induced platelet aggregation (RIPA). Nonetheless, data is lacking on the utility of LTA for investigating thrombocytopenic patients and platelet rich plasma samples with low platelet counts (L‐PRP). Previously, we developed a strategy for diagnostic LTA assessment of L‐PRP that included: (1) acceptance of referrals/samples, regardless of thrombocytopenia severity, (2) tailored agonist selection, based on which are informative for L‐PRP with mildly or severely low platelet counts, and (3) interpretation of maximal aggregation (MA) using regression‐derived 95% confidence intervals, determined for diluted control L‐PRP (C‐L‐PRP).

Methods

To further evaluate the L‐PRP LTA strategy, we evaluated findings for a subsequent patient cohort.

Results

Between 2008 and 2021, the L‐PRP strategy was applied to 211 samples (11.7% of all LTA samples) from 192 unique patients, whose platelet counts (median [range] × 10 9 /L) for blood and L‐PRP were: 105 [13–282; 89% with thrombocytopenia] and 164 [17–249], respectively. Patient‐L‐PRP had more abnormal MA findings than simultaneously tested C‐L‐PRP ( p ‐values

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand DiseasesThrombocytopeniaBlood Platelet DisordersPlatelet-Rich PlasmaHumansPlatelet CountPlatelet AggregationPlatelet Function TestsBlood Platelets

Stichwörter der Autor:innen

hemostatic disordersplatelet aggregationplatelet countplatelet function teststhrombocytopenia

Autor:innen und Institutionen

  • Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada.

ORCID-Profile: Rahaf Mahmoud Altahan, Natalie Mathews, Alex Bourguignon, Subia Tasneem, Donald M Arnold, Wendy Lim, Catherine P M Hayward

Förderung

  • McMaster University

Zitieren

APA

Altahan, R. M., Mathews, N., Bourguignon, A., Tasneem, S., Arnold, D. M., Lim, W., & Hayward, C. P. M. (2024). Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14216

Vancouver

Altahan RM, Mathews N, Bourguignon A, Tasneem S, Arnold DM, Lim W, et al. Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts. International Journal of Laboratory Hematology. 2024. doi:10.1111/ijlh.14216

BibTeX
@article{Altahan2024,
  author = {Altahan, Rahaf Mahmoud and Mathews, Natalie and Bourguignon, Alex and Tasneem, Subia and Arnold, Donald M and Lim, Wendy and Hayward, Catherine P M},
  title = {Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts},
  journal = {International Journal of Laboratory Hematology},
  year = {2024},
  doi = {10.1111/ijlh.14216}
}
Kostenlos starten →